MATHEW BAUERLE: Open Payments
NPI 1154790384 · PUNTA GORDA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$446 in 18 payments from 8 companies in 2025. Trend: 2023 $640 · 2024 $511 · 2025 $446
Food & beverage: $377Education: $69
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $143 |
| ABBVIE INC. | 4 | $109 |
| Amgen Inc. | 4 | $71 |
| SANOFI-AVENTIS U.S. LLC | 1 | $37 |
| PFIZER INC. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Corcept Therapeutics | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: QULIPTA, Veozah, EVENITY, TZIELD, UBRELVY, OTEZLA, NURTEC ODT, Sunosi.
Industry payments across FL — which companies pay providers there.
